Melasma Drug Treatment Market Expected to Reach US$ 5.2 Billion by 2031, Driven by Strong 8.3% CAGR: TMR Study
Wilmington, Delaware, United States, July 19, 2023 (GLOBE NEWSWIRE) -- The global melasma drug treatment market was valued at US$ 2.6 Bn in 2022 and is projected to expand at a CAGR of 8.3% from 2023 to 2031. Increase in demand for effective and safe …